Abstract
We examined whether circulating adiponectin levels are associated with further cardiovascular events in patients with type 2 diabetes. Between December 2004 and February 2005, 349 patients with type 2 diabetes were enrolled and followed-up until December 2015. Blood levels of total, middle-molecular weight and high-molecular weight adiponectin were measured at baseline. The primary composite outcome was the occurrence of the following events: cardiovascular death, non-fatal myocardial infarction, non-fatal stroke or hospitalization for unstable angina and heart failure. During a median follow-up of 9 years, cardiovascular events occurred in 14% of patients (50/349, 1.9% per year). Median blood levels of total, middle-molecular weight and high-molecular weight adiponectin were 4.8, 3.2 and 1.8 μg/mL, respectively. The cumulative incidence of cardiovascular events was not significantly different between the three groups based on total, middle-molecular weight, high-molecular weight or high-molecular weight/total adiponectin. After adjustment for potential confounding factors, blood adiponectin levels were positively associated with an increased number of cardiovascular events, but between tertiles, there was no significant differ...Continue Reading
References
Mar 27, 1999·Biochemical and Biophysical Research Communications·Y AritaY Matsuzawa
Dec 6, 2002·Journal of the American Society of Nephrology : JASN·Carmine ZoccaliPietro Finocchiaro
Jan 29, 2005·Diabetes·Matthias B SchulzeFrank B Hu
Feb 26, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Robert S LindsayLyle G Best
Aug 4, 2005·The Journal of Clinical Endocrinology and Metabolism·Debbie A LawlorNaveed Sattar
Aug 9, 2006·Circulation·Naveed SattarPeter H Whincup
Dec 21, 2006·Atherosclerosis·Soo LimKyong Soo Park
Aug 19, 2007·The American Journal of Cardiology·Teruo InoueKoichi Node
Dec 22, 2007·Stroke; a Journal of Cerebral Circulation·Masatoshi MatsumotoEiji Kajii
Jan 31, 2008·Clinical Science·Weidong ZhuAimin Xu
Jul 9, 2009·JAMA : the Journal of the American Medical Association·Shanshan LiRob M van Dam
Sep 8, 2010·Endocrine Journal·Wei-Chin HungYau-Jiunn Lee
May 17, 2013·Atherosclerosis·Isao SaitoHiroyasu Iso
Sep 10, 2014·Cardiovascular Diabetology·Claudia MenzaghiVincenzo Trischitta
Jun 16, 2015·International Journal of Endocrinology·Dagmar HorákováHelena Kollárová
Oct 28, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·Gang LiuQi Sun